Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.indswift.com | |
Market Cap | 49.40 Cr. | |
Enterprise Value(EV) | 1,042.01 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 4.81 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 1.90 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 33.57 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | -120.25 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | -0.08 | Calculated using Price: 9.12 |
Dividend Yield | 0.00 | Period Ending 2018-03 |
No. of Shares Subscribed | 5.42 Cr. | 54,164,653 Shares |
FaceValue | 2 | |
About Ind-Swift Ltd. | ||
Ind-Swift Limited was incorporated as a public limited company on June 6, 1986 under the Companies Act 1956.It is the flagship company of India based Ind Swift Group. Ind-Swift Limited is a north India based pharmaceutical company. |
1 Day |
|
-0.65% |
1 Week |
|
-3.70% |
1 Month |
|
+2.24% |
3 Month |
|
+16.92% |
6 Month |
|
-13.23% |
1 Year |
|
-17.69% |
2 Year |
|
+93.63% |
5 Year |
|
+26.32% |
10 Year |
|
+23.24% |
3 years | 2016-03 | 2017-03 | 2018-03 | |
Return on Equity (%) | ||||
Return on Capital Employed (%) | -22.84 | -56.70 | -10.34 | |
Return on Assets (%) | -18.95 | -42.37 | -8.46 |
Particulars | 5 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2022-03* Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | -245 | -616 | -663 | -720 | -705 | |
Non Curr. Liab. | 679 | 672 | 680 | 634 | 418 | |
Curr. Liab. | 621 | 608 | 598 | 718 | 936 | |
Minority Int. | ||||||
Equity & Liab. | 1,055 | 665 | 615 | 632 | 649 | |
Non Curr. Assets | 433 | 458 | 429 | 389 | 376 | |
Curr. Assets | 612 | 206 | 186 | 242 | 273 | |
Misc. Exp. not W/O | 10 | |||||
Total Assets | 1,055 | 665 | 615 | 632 | 649 |
Particulars | 4 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 304 | 263 | 270 | 411 | |
Other Income | 13 | 14 | 15 | 12 | |
Total Income | 317 | 277 | 284 | 423 | |
Total Expenditure | -461 | -328 | -264 | -369 | |
PBIDT | -144 | -52 | 21 | 54 | |
Interest | -19 | -16 | -11 | -60 | |
Depreciation | -36 | -36 | -35 | -29 | |
Taxation | 0 | -1 | -1 | ||
Exceptional Items | -260 | -28 | 61 | ||
PAT | -200 | -364 | -54 | 26 | |
Minority Interest | |||||
Share Associate | -14 | -8 | 4 | ||
Other Related Items | |||||
Consolidated Net Profit | -214 | -373 | -50 | 26 | |
Adjusted EPS | -42 | -69 | -9 | 5 |
Particulars | 3 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. |
Cash Fr. Operatn. | -119 | -2 | 7 | |
Cash Fr. Inv. | 10 | 4 | -6 | |
Cash Fr. Finan. | 110 | -11 | -6 | |
Net Change | 0 | -8 | -5 | |
Cash & Cash Eqvt | 17 | 9 | 4 |
Thu, 01 Jun 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper publication of Financial results for the quarter and financial year ended 31.03.2023 |
Tue, 30 May 2023
Audited Standalone & Consolidated Financial Results Of Ind-Swift Limited For The Fourth Quarter (Q4) And Financial Year Ended 3 1" March 2023. Audited Standalone & Consolidated Financial Results of Ind-Swift Limited for the Fourth Quarter (Q4) and Financial Year ended 3 1" March 2023. |
Tue, 30 May 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 30.05.2023 Outcome of Board Meeting |
Fri, 09 Jun 2023 |
|
|
|
|
Thu, 08 Jun 2023 |
|